You have 9 free searches left this month | for more free features.

MND

Showing 1 - 25 of 112

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

ALS, PLS, MND (Motor Neurone DIsease) Trial in Italy, United States

Recruiting
  • ALS
  • +5 more
    • Gainesville, Florida
    • +8 more
    Jul 20, 2023

    ALS Trial in New York (Mag Stim)

    Terminated
    • ALS
    • Mag Stim
    • New York, New York
      Shara Holzberg
    Nov 9, 2022

    Motor Neuron Disease, Amyotrophic Lateral Sclerosis Trial (Telemonitoring via Careportal®)

    Not yet recruiting
    • Motor Neuron Disease, Amyotrophic Lateral Sclerosis
    • Telemonitoring via Careportal®
    • (no location specified)
    Mar 18, 2022

    Hypertriglyceridemia Trial in Tokyo (Icosapent)

    Completed
    • Hypertriglyceridemia
    • Tokyo, Japan
      Mochida Investigational sites
    Aug 19, 2021

    Motor Neuron Disease Trial in London (High-density surface EMG, Ultrasound)

    Completed
    • Motor Neuron Disease
    • High-density surface EMG
    • Ultrasound
    • London, United Kingdom
      King's College Hospital NHS Foundation Trust
    Mar 29, 2022

    Motor Neuron Disease, Amyotrophic Lateral Sclerosis Trial in United Kingdom (Virtual peer-to-peer support)

    Recruiting
    • Motor Neuron Disease
    • Amyotrophic Lateral Sclerosis
    • Virtual peer-to-peer support
    • Bedford, United Kingdom
    • +14 more
    Aug 16, 2022

    Amyotrophic Lateral Sclerosis Trial in Macquarie Park (Cu(II)ATSM)

    Completed
    • Amyotrophic Lateral Sclerosis
    • Macquarie Park, New South Wales, Australia
      Macquarie University
    Feb 15, 2022

    Severe Combined Immunodeficiency Trial in Los Angeles (ADA gene transfer)

    Completed
    • Severe Combined Immunodeficiency
    • ADA gene transfer
    • Los Angeles, California
      University of California, Los Angeles
    Apr 21, 2021

    The Living With a Long-Term Condition Study

    Recruiting
    • Asthma
    • +44 more
    • Living with LTC Questionnaire
    • London, United Kingdom
      King's College London
    Oct 10, 2023

    Amyotrophic Lateral Sclerosis, Motor Neuron Disease Trial in Birmingham (ILB)

    Completed
    • Amyotrophic Lateral Sclerosis
    • Motor Neuron Disease
    • Birmingham, West Midlands, United Kingdom
      University Hospitals Birmingham NHS Foundation Trust
    Oct 4, 2021

    Motor Neuron Disease / Amyotrophic Lateral Sclerosis Trial in Australia (Intervention polysomnography, Sham polysomnography)

    Recruiting
    • Motor Neuron Disease / Amyotrophic Lateral Sclerosis
    • Intervention polysomnography
    • Sham polysomnography
    • Adelaide, Australia
    • +12 more
    Jun 19, 2022

    Amyotrophic Lateral Sclerosis Trial in Worldwide (Lithium Carbonate 400 MG)

    Recruiting
    • Amyotrophic Lateral Sclerosis
    • Lithium Carbonate 400 MG
    • Adelaide, Australia
    • +12 more
    Aug 21, 2023

    Amyotrophic Lateral Sclerosis Trial in France, United Kingdom (Riluzole, IL-2, 5% glucose water solution)

    Completed
    • Amyotrophic Lateral Sclerosis
    • Lille, France
    • +16 more
    Apr 1, 2022

    Hyperkinetic Movements in Disease of Motor Neurons and Their

    Recruiting
    • Tremor
    • +3 more
    • Ljubljana, Slovenia
      University Medical Centre Ljubljana
    Mar 30, 2021

    Genomic Translation for Amyotrophic Lateral Sclerosis Care

    Completed
    • ALS
      • Los Angeles, California
      • +13 more
      Aug 18, 2022

      Tissue Bank for Understanding of Motor Neuron Disease

      Suspended
      • Amyotrophic Lateral Sclerosis
        • Charlotte, North Carolina
          Neurosciences Institute, Neurology - Charlotte
        Dec 24, 2019

        Motor Neuron Disease Trial in Sydney, Melbourne (Monepantel)

        Recruiting
        • Motor Neuron Disease
        • Sydney, New South Wales, Australia
        • +1 more
        Jun 28, 2022

        Motor Neuron Disease, Amyotrophic Lateral Sclerosis Trial in United Kingdom (Memantine Hydrochloride Oral Solution, Trazodone

        Recruiting
        • Motor Neuron Disease, Amyotrophic Lateral Sclerosis
        • Memantine Hydrochloride Oral Solution
        • +2 more
        • Aberdeen, United Kingdom
        • +7 more
        May 10, 2022

        Hypertriglyceridemia Trial in Tokyo (Icosapent (MND-2119), Icosapent (EPADEL CAPSULES 300))

        Completed
        • Hypertriglyceridemia
        • Icosapent (MND-2119)
        • Icosapent (EPADEL CAPSULES 300)
        • Tokyo, Japan
          Mochida Investigational sites
        Jul 30, 2019

        Respiratory Complications in ALS

        Completed
        • Motor Neuron Disease
        • Pneumonia
        • Questionaires
        • Liverpool, United Kingdom
          LiverpoolUHNHS
        Sep 21, 2021

        Amyotrophic Lateral Sclerosis, Motor Neuron Disease Trial in Sydenham, Caulfield (Cu(II)ATSM)

        Completed
        • Amyotrophic Lateral Sclerosis
        • Motor Neuron Disease
        • Sydenham, New South Wales, Australia
        • +1 more
        Mar 15, 2020

        Motor Neuron Disease/Frontal Dementia Spectrum Disease in China

        Enrolling by invitation
        • Amyotrophic Lateral Sclerosis
        • +2 more
          • Beijing, Beijing, China
            Dongsheng Fan
          Jul 13, 2021

          Arterial Stiffness and Respiratory Failure in Motor Neurone

          Completed
          • Motor Neurone Disease
          • Hypoxemia and/or Hypercapnia
          • Non Invasive Ventilation
          • Without Non Invasive Ventilation
          • London, United Kingdom
          • +1 more
          Sep 30, 2021

          Amyotrophic Lateral Sclerosis Trial in Macquarie (Cu(II)ATSM, Placebos)

          Unknown status
          • Amyotrophic Lateral Sclerosis
          • Macquarie, New South Wales, Australia
            Macquarie University
          Nov 4, 2019

          Amyotrophic Lateral Sclerosis Trial in Sydney (Cu(II)ATSM)

          Active, not recruiting
          • Amyotrophic Lateral Sclerosis
          • Sydney, New South Wales, Australia
            Macquarie University
          Feb 15, 2022